Skip to content

Add on effect of Alabu Modaka in women with heavy menstrual bleeding

Efficacy of Alabu Modaka as an add on to Bolabaddha rasa in Menorrhagia hypen A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101254
Enrollment
24
Registered
2026-01-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

None listed

Sponsors

VPSV Ayurveda college kottakkal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Prolonged menstrual bleeding of more than 7 days and or or excessive menstrual bleeding with PBAC score greater than 100 2. Participant with Hb greater than 8 g% 3. Participants diagnosed with fibroid uterus 4. Willingness to provide informed written consent

Exclusion criteria

Exclusion criteria: 1. Participants with intermenstrual bleeding 2. Bleeding associated with OCP and IUCD 3. Participants diagnosed with any form of malignancy 4. Participants on prolonged medication for systemic illnesses like thyroid dysfunction, diabetes mellitus, severe hypertension, liver cirrhosis, congestive cardiac failure 5. Participants who have received hormonal therapy within the past 3 months 6. Participants with known coagulation disorders

Design outcomes

Primary

MeasureTime frame
Changes in the PBAC scoresTimepoint: 1st assessment: On the day of 1st OPD visit 2nd assessment: After the bleeding phase of 1st cycle 3rd assessment: After the bleeding phase of 2nd cycle 4th assessment: After the bleeding phase of 3rd cycle Follow-up: After the bleeding phase of 4th cycle

Secondary

MeasureTime frame
Menstrual bleeding questionnaire for quality of life assessmentTimepoint: 1st assessment: On the day of 1st OPD visit 2nd assessment: After the bleeding phase of 1st cycle 3rd assessment: After the bleeding phase of 2nd cycle 4th assessment: After the bleeding phase of 3rd cycle Follow-up: After the bleeding phase of 4th cycle

Countries

India

Contacts

Public ContactDr M C Shobhana

VPSV Ayurveda College Kottakkal

drshobhamc@gmail.com9446321535

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026